Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Novel Strategies for Improved Treatment of O6-Methylguanine-DNA Methyltransferase Promoter-Methylated Glioma.
Journal: Medical research archives
Published: October 31, 2025
DNA damage response profile distinguishes poor-acting gliomas with shared methylome signatures.
Journal: Neuro-oncology
Published: September 01, 2025
Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes.
Journal: NAR cancer
Published: June 17, 2025
DNA repair helicases: from mechanistic understanding to therapeutic implications.
Journal: NAR cancer
Published: June 11, 2025
Development of Syngeneic Murine Glioma Models with Somatic Mismatch Repair Deficiency to Study Therapeutic Responses to Alkylating Agents and Immunotherapy.
Journal: Current protocols
Published: February 25, 2025
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.
Journal: Neuro-oncology
Published: December 10, 2024
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
Journal: Current treatment options in oncology
Published: September 19, 2022
Mechanism-based design of agents that selectively target drug-resistant glioma.
Journal: Science (New York, N.Y.)
Published: July 28, 2022
Oncometabolites as Regulators of DNA Damage Response and Repair.
Journal: Seminars in radiation oncology
Published: December 04, 2021
Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51.
Journal: Science translational medicine
Published: September 17, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026